TGFB1 and congenital disorder of glycosylation: These findings suggest that GO can be regarded as a congenital disorder of glycosylation (CDG) leading to a disorganized collagen network and TGF-β activation due to abnormal function of the underglycanated proteoglycans, including decorin and biglycan.